Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Clinical trial NCT07130903 · RECRUITING
Trial details
- NCT number
- NCT07130903
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2028-04-17
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.